VideaHealth

Decision/Risk Analysis · Boston, MA · Founded 2018 · Privately Held (backing)

Developer of an artificial intelligence technology designed to detect pathologies in dental imaging automatically. VideaHealth is based in Boston, MA and was founded in 2018. It was valued at $400 million at its later-stage round in Jan 2025, the last priced event on record. It has raised $65.4 million across 4 recorded rounds; the latest was a $40 million Series B in Jan 2025.

PMV mark · valuation
$400.0M
Oct 2026
Priced at
its later-stage round
Jan 2025
Total raised
$65.4M
Last round
Later Stage VC (Series B)
Jan 2025
What is VideaHealth worth?
$400.0MPrivateMarketView mark · Oct 2026

Valued at $400.0M at its later-stage round, Jan 2025. Nothing has traded since.

Free account
More of VideaHealth with a free account
  • ·The complete investor list: 14 names
  • ·Watch VideaHealth: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

VideaHealth funding history

4 rounds
DateRoundRaisedPost-money
Jan 2025Later Stage VC (Series B)$40.0M▮
Mar 2022Early Stage VC (Series A)$20.0M▮
Sep 2019Early Stage VC$5.4M▮
Dec 2018Seed Round$1.0M▮
Unlock post-money valuations

Membership and data by Private Market View

VideaHealth valuation

VideaHealth was valued at $400 million at its later-stage round in Jan 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has VideaHealth raised?

VideaHealth has raised $65.4 million across 4 recorded rounds since 2018. The largest was a $5.4 million early-stage round in Sep 2019; the most recent was a $40 million Series B in Jan 2025.

VideaHealth has filed 3 Form Ds with the SEC since 2019, most recently in Mar 2022 ($20 million sold to 6 investors).

Comparable companies

Comparable decision/risk analysis names by valuation on PrivateMarketView: HeartFlow (NAS: HTFL) ($1.5 billion), Anumana ($580 million) and Inductive Bio ($80 million).

How VideaHealth's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For VideaHealth, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →

Frequently asked about VideaHealth

What is VideaHealth worth?
VideaHealth is valued at $400.0M as of Oct 2026. Valued at $400.0M at its later-stage round, Jan 2025. Nothing has traded since.
How much has VideaHealth raised?
VideaHealth has raised $65.4M in total funding across 4 recorded rounds.
When did VideaHealth last raise?
VideaHealth last raised in Jan 2025 (Later Stage VC (Series B)), raising $40.0M.